Agent Trial
Trading Prediction Markets AI Agent Context Fastest News API Agent Trial Log In Sign Up
News Wire / economy

AbbVie Acquires Apogee Therapeutics For $10.9 Billion

N-TV Audio North Chicago 16h15h Impact 10
AbbVie has acquired Apogee Therapeutics for approximately $10.9 billion. The acquisition aims to expand AbbVie's pipeline with advanced immunology and oncology programs. Apogee Therapeutics is known for its development of novel therapies. This deal is expected to bolster AbbVie's pipeline in the biopharmaceutical sector. The acquisition is subject to customary closing conditions. The acquisition is aimed at strengthening AbbVie's drug pipeline. The terms of the deal were not further elaborated.

Topics

mergers and acquisitions pharmaceuticals biotechnology

Developing

  1. 903d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
  2. 903d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
  3. 903d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
  4. 903d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.

Sources · 7 independent

N-TV Audio

“EILMELDUNG - AbbVie übernimmt ApogeeTherapeutics für rund 10,9 Milliarden US-Dollar. Damit erweitert der Pharmakonzern seine Pipeline um fortgeschrittene Programme in den Bereichen Immunologie und...”

Bloomberg Radio

“AbbVie has acquired Apogee Therapeutics for $10.9 billion.”

REPLAY NEWS - English News radio every 5 minutes

“Four Raising the spect Of renew Renewed Сенсоші Censorship Traffic analys Graphic analysis And spe Yeah Enforcement with them More than thir More than thirteen”

Bloomberg AM New York, NY

“us now On Bloomberg TV It's good to I was like I met with Tony Bl Tony Blair Most six Сукцефо They lose And that's”

Bloomberg AM New York

“us now On Bloomberg TV It's good to I was like I met with Tony Bl Tony Blair Most six Сукцефо They lose And that's”

Radio Popolare|Milan, Europe

“hmm Okay need Yeah sesto dal Brexit petrolio irani Yeah No no Libano e nuc nucleare Until Anticiclone Domani quind Блекаут Dumania Lert Sindacati Ye”

Bloomberg AM New York, NY

“AbbVie has announced the acquisition of Apogee Therapeutics for $10.9 billion. This significant deal is expected to bolster AbbVie's pipeline in the biopharmaceutical sector. The acquisition is subject to customary closing conditions.”

Radio Nacional del Perú

“Oh Yeah I know A noche salí Oh Olvida Olvidar tu rec Tule cu KURI TO Да бога Okay He can Y que con conseguir”

Bloomberg Radio

“AbbVie is acquiring Apogee Therapeutics for $10.9 billion.”

Bloomberg AM New York, NY

“AbbVie has announced its acquisition of Apogee Therapeutics for approximately $10.9 billion.”

Business News Network

“Prozac You are L The kind of culture That's made it Аксес там Yeah Lily has No vol Novo Nordis Pioneer the But Eli Lill”

96.3 Beat Fm

“diamol We did a cac Какао Mukunja Kunja wechu But Bekajingo Les bêtises Nab Now cool c Vamos Pira What Waka tua With FM presenters”

Bloomberg 960

“Yeah It' Not y Think to yourself Yeah Everybody's Marino Oh L what even Dan Marina Marino drops So Хисторикли Many of our great cor”

Radio Okapi

“Mikey Lob Bah coupe Some mabakis C pe Bakob Осо ою Kakata Nou Bouquet co Que coca bo Kabulate But Oyo Bazal Azalina B L'inaboko”

Radio metropolitana Arequipa

“Давай я бе Pero Oh Vamos a bailar Se bailar la c la cumbia Yeah Uh Porque Hello El mundo entero Legosa So Oh Bailami”

Bloomberg 960

“You can't bell I think Uh And I'm with you like ever Every time one of these Stories comes just Це мі Yeah like n”

90.7 WMFE-FM

“AbbVie has acquired Apogee Therapeutics for $10.9 billion.”

680 News Toronto

“radio Toron Uh sevent And has we did Academy А стоп A one and a half Yeah A sentencing hear Hearing is set for December”

Unlock the full story

Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.

Log in to upgrade